Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pose, M. B. Schaefer, J. Ott, M. Bi, A. Mohr, F. Grimminger, W. Seeger, K. Mayer (Giessen, Germany; Bejing, China). Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury. Eur Respir J 2006; 28: Suppl. 50, 3352

Member's Comments

No comment yet.

Related content which might interest you: Peroxisome proliferator-activated receptor-α reduces inflammation and vascular leakage in a murine model of acute lung injury Source: Eur Respir J 2008; 32: 1344-1353 Year: 2008 Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles Source: Eur Respir J 2011; 37: 1494-1502 Year: 2011 Role of exogenous ligands for the peroxisome proliferator-activated receptor-β/δ in the development of bleomycin-induced lung injury Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir Rev 2006; 15: 211-212 Year: 2006 Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006 Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury Source: Eur Respir J 2005; 25: 225-234 Year: 2005 Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Source: Eur Respir J 2008; 31: 502-508 Year: 2008 PPAR-γ agonists as therapy for diseases involving airway neutrophilia Source: Eur Respir J 2004; 24: 18-23 Year: 2004 Effects of peroxisome proliferators-activated receptor-α, γ agonists on acute lung injury rats induced by lipopolysaccharide Source: Eur Respir J 2006; 28: Suppl. 50, 397s Year: 2006 The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007 Improvement of ventilation-induced diaphragm dysfunction through toll-like receptor 4 and nuclear factor-?B in a murine sepsis model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Regulation of eotaxin gene transcription by peroxisome proliferator-activated receptor γ agonists in human airway smooth muscle cells: interactions with glucocorticoids and β2-agonists Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions Year: 2005 Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD Source: Annual Congress 2006 - Respiratory muscles Year: 2006 Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema Source: International Congress 2017 – Experimental PH Year: 2017 Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007 Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD Source: Eur Respir J 2007; 30: 245-252 Year: 2007 Impacts of peroxisome proliferator-activated receptor gamma activation on cigarette smoke-induced exacerbated response to bacteria Source: Eur Respir J 2015; 45: 191-200 Year: 2015 Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment Source: Eur Respir J 2012; 40: 416-423 Year: 2012 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015